Taurus Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Taurus Asset Management, LLC

$944 Million
Q2 2024

A detailed history of Taurus Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Taurus Asset Management, LLC holds 16,041 shares of REGN stock, worth $18.5 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares

16,041

Previous 15,907 0.84%

Holding current value

$18.5 Million

Previous $15.3 Million 10.12%

% of portfolio

1.79%

Previous 1.63%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$883.2 - $1071.19 $118,348 - $143,539	134 Added 0.84%	16,041 $16.9 Million
Q1 2024 May 08, 2024	SELL	$902.69 - $993.35 $132,695 - $146,022	-147 Reduced 0.92%	15,907 $15.3 Million
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $56,588 - $64,364	-73 Reduced 0.45%	16,054 $14.1 Million
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $55,396 - $67,549	-80 Reduced 0.49%	16,127 $13.3 Million
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $494,221 - $586,227	-706 Reduced 4.17%	16,207 $11.6 Million
Q1 2023 May 08, 2023	SELL	$680.49 - $826.97 $13.8 Million - $16.7 Million	-20,226 Reduced 54.46%	16,913 $13.9 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $600,712 - $652,197	-851 Reduced 2.24%	37,139 $26.8 Million
Q3 2022 Nov 09, 2022	SELL	$573.97 - $724.32 $3.36 Million - $4.24 Million	-5,850 Reduced 13.34%	37,990 $26.2 Million
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $1.37 Million - $1.84 Million	-2,492 Reduced 5.38%	43,840 $25.9 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $267,804 - $314,293	-450 Reduced 0.96%	46,332 $32.4 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $157,609 - $194,581	290 Added 0.62%	46,782 $29.5 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $54,532 - $64,691	-95 Reduced 0.2%	46,492 $28.1 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $200,940 - $237,379	425 Added 0.92%	46,587 $26 Million
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $20.6 Million - $25.3 Million	46,162 New	46,162 $21.8 Million

Others Institutions Holding REGN

# of Institutions

1,461

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $124B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taurus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taurus Asset Management, LLC with notifications on news.

Account

Taurus Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History